Recent Mergers and Acquisitions

SomaLogic, Inc. acquisition by CM Life Sciences II Inc.

SomaLogic, a privately-owned protein biomarker discovery and diagnostics company, was acquired by CM Life Sciences II (NASDAQ: CMII), a special purpose acquisition company, for $651 million. 

Morrow Sodali acted as the proxy solicitor for the target in this transaction.

Find more information here.

SomaLogic, Inc. acquisition by CM Life Sciences II Inc.

SomaLogic, a privately-owned protein biomarker discovery and diagnostics company, was acquired by CM Life Sciences II (NASDAQ: CMII), a special purpose acquisition company, for $651 million. 

Morrow Sodali acted as the proxy solicitor for the target in this transaction.

Find more information here.